Last Price$37.29.3%
Market Cap$3,309.7M
4.9x
Industry median - 4.4x
5Y Historical average - 4.2x
4.2x
Industry median - 1.0x
5Y Historical average - 2.7x
FCF to Interest
(9.3x)
Industry median - (29.0x)
5Y Historical average - (213.5x)
31.1%
Industry median - 3.8%
5Y Historical average - 19.1%
LEGN Health Rating
LEGN Health rating
6.7
LEGN Health rating performance
LEGN Financial Stability & Strength
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
FCF to Interest
Intangibles as % of Total Assets
Competing with LEGN Financial Health
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Net Debt | Health score | Current ratio | Quick ratio | Net Debt to FCF | FCF to Interest | Intangibles as % of Total Assets | Total Debt to Equity |
$3,309.7M | ($865.8M) | 6.7 | 5.0x | 4.9x | 4.2x | (9.3x) | 10.1% | 31.1% | |
$124.8B | ($4,366.4M) | 5.8 | 2.7x | 2.2x | 5.5x | (25.8x) | 3.7% | 10.7% | |
$77.0B | ($15.9B) | 6.6 | 33.5x | 29.7x | (4.4x) | 65.2x | 3.0% | 5.7% | |
$34.4B | N/A | 5.6 | N/A | N/A | N/A | (103.5x) | N/A | N/A | |
$30.7B | ($1,398.5M) | 6.9 | 2.8x | 2.6x | 32.8x | (0.3x) | 0.0% | 1,931.9% | |
$24.0B | (€16.5B) | 6.8 | 7.5x | 7.3x | 71.9x | (11.5x) | 3.5% | 1.3% | |
$14.5B | $5,841.4M | 4.7 | 1.4x | 1.4x | 2.1x | 12.3x | 0.0% | 73.6% | |
$13.8B | ($2,967.0M) | 6.9 | 5.2x | 4.8x | (2.7x) | 25.2x | 1.1% | 4.7% | |
$13.4B | ($535.0M) | 6.1 | 5.3x | 3.0x | (1.1x) | 38.5x | 3.7% | 10.7% | |
$13.3B | ($405.1M) | 6.8 | 10.2x | 9.9x | 2.9x | (16.4x) | 0.0% | 1.9% | |
$1,846.9M | ($1,600.5M) | 4.3 | 1.9x | 1.6x | 1.5x | N/A | 0.9% | 32.1% |
FAQ
What is the Legend Biotech Corporation (LEGN) quick ratio?
The Legend Biotech Corporation (LEGN) quick ratio is 4.9x, compared to the industry median of 4.4x and the 5-year historical average of 4.2x.
What is the Legend Biotech Corporation (LEGN) net debt to Free Cash Flow (FCF) ratio?
The Legend Biotech Corporation (LEGN) net debt to FCF ratio is 4.2x, compared to the industry median of 1.0x and the 5-year historical average of (2.7x).
What is Legend Biotech Corporation (LEGN) Free Cash Flow (FCF) to interest ratio?
Legend Biotech Corporation (LEGN) FCF to interest ratio is (9.3x), compared to the industry median of (29.0x) and the 5-year historical average of (213.5x).
What is the Legend Biotech Corporation (LEGN) total debt to equity ratio?
The Legend Biotech Corporation (LEGN) total debt to equity ratio is 31.1%, compared to the industry median of 3.8% and the 5-year historical average of 19.1%.